Last reviewed · How we verify
NCT06185868
Clinical Research Plan for Human Myopia Models
trial testing No intervention measures in Human Myopia Model in 2,000 participants. Completed in 30 October 2022.
30 October 2022
Quick facts
| Lead sponsor | Robotrak Technologies Co., Ltd. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 May 2022 |
| Primary completion | 30 October 2022 |
| Estimated completion | 30 October 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- No intervention measures
Conditions studied
- Human Myopia Model — all drugs for Human Myopia Model →
Sponsor
Robotrak Technologies Co., Ltd.
Who can join
Adults 6 to 16, any sex, with Human Myopia Model. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Collect optical biological parameters, refractive index data, and other related parameters of myopia and refractive errors in children and adolescents, and establish an optical model of myopia in children and adolescents.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06185868
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention measures
Trials testing the same drug.
- NCT07376590 — Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms · recruiting
- NCT06739746 — Research on the Sources of Noise in Post Anesthesia Care Unit and the Impact of Noise on Medical Staff · not yet recruiting
- NCT06969599 — A Cross-sectional Study on the Correlation Between Screen Usage and Sleep and Cognition in Medical Students · not yet recruiting
- NCT06621186 — Construction of an in Vitro Intestinal Microbial Ecological Simulation System for Obese People · completed
- NCT06173414 — Adaptive Optics ScanningLaser Ophthalmoscope Safety and Efficacy Clinical Trial · completed
Other Robotrak Technologies Co., Ltd. trials
Trials by the same sponsor.
- NCT06173414 — Adaptive Optics ScanningLaser Ophthalmoscope Safety and Efficacy Clinical Trial · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06185868 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Robotrak Technologies Co., Ltd.
- Last refreshed: 29 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06185868.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing